Xior Student Housing Valuation

Is 0RD8 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0RD8 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0RD8 (€30.1) is trading below our estimate of fair value (€38.9)

Significantly Below Fair Value: 0RD8 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0RD8?

Key metric: As 0RD8 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0RD8. This is calculated by dividing 0RD8's market cap by their current revenue.
What is 0RD8's PS Ratio?
PS Ratio6.2x
Sales€205.81m
Market Cap€1.27b

Price to Sales Ratio vs Peers

How does 0RD8's PS Ratio compare to its peers?

The above table shows the PS ratio for 0RD8 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average9.1x
ESP Empiric Student Property
7.2x8.5%UK£590.8m
UTG Unite Group
11.7x10.9%UK£4.2b
SOHO Triple Point Social Housing REIT
5.9x4.1%UK£240.8m
HOME Home Reit
11.5xn/aUK£300.8m
0RD8 Xior Student Housing
6.2x-0.7%€1.3b

Price-To-Sales vs Peers: 0RD8 is good value based on its Price-To-Sales Ratio (6.2x) compared to the peer average (8.3x).


Price to Sales Ratio vs Industry

How does 0RD8's PS Ratio compare vs other companies in the European Residential REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
0RD8 6.2xIndustry Avg. 9.1xNo. of Companies5PS0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0RD8 is good value based on its Price-To-Sales Ratio (6.2x) compared to the European Residential REITs industry average (9.1x).


Price to Sales Ratio vs Fair Ratio

What is 0RD8's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0RD8 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.2x
Fair PS Ratio7.5x

Price-To-Sales vs Fair Ratio: 0RD8 is good value based on its Price-To-Sales Ratio (6.2x) compared to the estimated Fair Price-To-Sales Ratio (7.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0RD8 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€30.10
€37.00
+22.9%
9.3%€42.00€31.00n/a9
Nov ’25€30.80
€37.00
+20.1%
9.3%€42.00€31.00n/a9
Oct ’25€34.40
€36.33
+5.6%
10.3%€40.00€30.00n/a9
Sep ’25€32.70
€34.89
+6.7%
11.3%€40.00€28.00n/a9
Aug ’25€31.30
€34.39
+9.9%
10.3%€38.00€28.00n/a9
Jul ’25€30.15
€33.72
+11.8%
12.7%€38.00€24.00n/a9
Jun ’25€28.40
€33.69
+18.6%
14.0%€39.00€24.00n/a8
May ’25€28.00
€33.69
+20.3%
14.0%€39.00€24.00n/a8
Apr ’25€27.98
€35.07
+25.4%
9.0%€39.00€30.00n/a7
Mar ’25€25.37
€35.36
+39.4%
9.1%€39.00€30.00n/a7
Feb ’25€27.22
€35.36
+29.9%
9.1%€39.00€30.00n/a7
Jan ’25€29.86
€35.00
+17.2%
11.2%€42.00€30.00n/a7
Dec ’24€31.08
€34.86
+12.1%
11.8%€42.00€29.00n/a7
Nov ’24€27.77
€34.83
+25.4%
12.7%€42.00€29.00€30.806
Oct ’24€27.13
€34.83
+28.4%
12.7%€42.00€29.00€34.406
Sep ’24€27.10
€34.83
+28.5%
12.7%€42.00€29.00€32.706
Aug ’24€27.70
€36.42
+31.5%
15.9%€44.00€29.00€31.306
Jul ’24€27.24
€36.38
+33.6%
12.9%€42.00€31.00€30.154
Jun ’24€28.14
€36.38
+29.3%
12.9%€42.00€31.00€28.404
May ’24€28.80
€36.38
+26.3%
12.9%€42.00€31.00€28.004
Apr ’24€31.00
€39.13
+26.2%
15.6%€48.00€31.00€27.984
Mar ’24€30.60
€39.63
+29.5%
13.7%€48.00€33.00€25.374
Feb ’24€31.32
€40.38
+28.9%
11.5%€48.00€36.00€27.224
Jan ’24€29.23
€47.70
+63.2%
20.5%€60.00€36.00€29.865
Dec ’23€27.60
€47.70
+72.9%
20.5%€60.00€36.00€31.085
Nov ’23€28.70
€52.40
+82.6%
17.0%€60.00€36.00€27.775

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies